A s fans patiently wait for the return of Omay Sy's Assane Diop in Lupin Season 4, Netflix has given little to no updates ...

Catalyst Pharma ( ($CPRX) ) has shared an announcement. On August 25, 2025, Catalyst Pharmaceuticals and its licensor SERB S.A. announced a ...

Catalyst Pharmaceuticals ( NASDAQ: CPRX) said that the company and licensor SERB S.A. signed a settlement agreement with ...

As Part of the Settlement, Lupin Receives a License to Market Generic FIRDAPSE Beginning in February 2035CORAL GABLES, Fla., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst ...

Catalyst Pharmaceuticals agreed to settle its litigation against Lupin Pharmaceuticals over Lupin's application to market a generic version of Catalyst's Lambert-Eaton myasthenic syndrome drug.

As the patent for semaglutide nears its end, Novo Nordisk's dominance in the weight-loss market is being challenged. The ...

As fans eagerly await the continuation of Assane Diop's captivating journey, the filming for the fourth and final season of Netflix's 'Lupin' is underway and expected to conclude ...

Glucagon is indicated for the treatment of severe hypoglycemia in patients with diabetes mellitus and as a diagnostic aid for ...

Omar Sy can be seen gallopping down the streets of Paris! Lupin has been in production for a good few months now across Paris, and the hit French show is now filming one of its biggest action ...

Mirae Asset Sharekhan is bullish on Lupin has recommended buy rating on the stock with a target price of Rs 2400 in its research report dated August 21, 2025.

To facilitate the filming, the Paris Prefecture has implemented several traffic restrictions on the following dates and locations: Between 9 AM and 12 PM: Rue Beethoven in the 16th arrondissement will ...

Lupin today announced the launch of Bosentan Tablets for Oral Suspension, 32 mg in the United States. This follows the approval received by Lupin's alliance partner, NATCO Pharma Limited (NATCO) for ...